$9.52
-0.05-0.52%
At close: -
$9.55
0.030.32%
After Hours: Nov 15, 4:31 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Theravance Biopharma in recent months.
Browse guidance and forecast on all stocks.